A promising study of a combination approach to HIV cure featured at last month’s Conference on Retroviruses and Opportunistic Infections in the US. The study looked at the impact of a broadly neutralising antibody (bNAb) together with an immune-activating compound in monkeys. Headed by Dan Barouch from the Beth Israel Deaconess Medical Center in Boston, the…
Understanding how HIV cure interventions affect women will move us closer to the goal of an HIV cure for everyone. Women and HIV HIV is a women’s issue. Worldwide, more than half of the 36.7 million people living with HIV are women. That equates to 18.6 million women and girls. Each year, another 1 million…
Researchers have revealed a new way to understand the HIV that stays in the body during therapy. The group from Sydney’s Westmead Institute for Medical Research have developed a technique for detailing HIV at a molecular level. Bonnie Hiener and colleagues, led by Associate Professor Sarah Palmer, published the study in the journal Cell Reports…
I. Introduction In recent years, a global movement has arisen towards finding a cure for HIV. While we remain many years away from a cure that could be offered to the almost 37 million people living with HIV throughout the world, researchers are exploring a number of approaches that might one day bring an end…
Scientists from the US have announced an improved way to detect hidden HIV. The group of Professor Phalguni Gupta at the University of Pittsburgh describe a new test for measuring latent HIV. Published in Nature Medicine, the test could be used to see how effective an HIV cure strategy is. Why is a new test…
CRISPR/cas9 is a gene-editing strategy acting like a targeted pair of scissors. The technology has generated a lot of excitement, especially in the field of HIV. This is because it can target specific genes, and potentially remove HIV from infected cells. A recent study has been widely reported this month as bringing us one step…
This article was originally published on The Conversation. Read the original article. Sharon Lewin, The Peter Doherty Institute for Infection and Immunity and Thomas Aagaard Rasmussen, The Peter Doherty Institute for Infection and Immunity Antiretroviral therapy has revolutionised the lives of people living with HIV. In many countries, the life expectancy for someone living with…
T cells that target HIV but are resistant to HIV infection are the latest strategy in the battle against HIV. Chimeric antigen receptor (CAR)-T cells are a concept also in development for treating cancer. Seattle researchers have published a new approach for developing CAR-T cells. This new strategy could eventually lead to better outcomes for people…
The international media have been at it again this week, with claims of an HIV cure thrown around in a sensationalist click-bait fest, amplified through social media channels and networks around the world. As we’ve warned before, these sorts of headlines should be read VERY carefully. So what’s behind all this attention, and what is…
The desire for a cure for HIV has existed since the start of the epidemic. In the 1980s, many people were optimistic that science would find a cure within a few years. However, as more was learned about the complexity of this retrovirus, hope of a cure gave way to the goal to develop effective…
HIV infection takes a heavy toll on the gut. The virus enters the body and heads straight for the stomach and intestines....
